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Background. The availability of a rapid diagnostic test for malaria (RDTm) allows accurate diagnosis at all
levels of health facilities. The objective of the present study was to evaluate the safety of withholding antimalarials
in febrile children who have a negative test result.
Methods. We conducted a prospective 2-arm longitudinal study in areas of Tanzania that are moderately and
highly endemic for malaria. Children with a history of fever were managed routinely by resident clinicians of 2
health facilities, except that no antimalarials were prescribed if the RDTm result was negative. Children were
followed up at home on day 7. The main outcome was the occurrence of complications in children with negative
RDTm results; children with positive RDTm results were followed up for the same outcomes for indirect comparison.
Results. One thousand children (median age, 24 months) were recruited. Six hundred three children (60%)
had a negative RDTm result. Five hundred seventy-three (97%) of these children were cured on day 7. Forty-nine
(8%) of the children with negative RDTm results spontaneously visited the dispensary before day 7, compared
with 10 (3%) of the children with positive RDTm results. All children who had negative initial results had negative
results again when they were tested either at spontaneous attendance or on day 7 because they were not cured
clinically, except for 3 who gave positive results on days 2, 4, and 7 respectively but who did not experience any
complication. Four children who had negative initial results were admitted to the hospital subsequently, all with
negative results for malaria tests upon admission. Two of them died, of causes other than malaria.
Conclusions. Not giving antimalarial drugs in febrile children who had a negative RDTm result was safe, even
in an area highly endemic for malaria. Our study provides evidence for treatment recommendations based on
parasitological diagnosis in children !5 years old.
The number of episodes of fever among African chil-
dren could be as high as 870 million per year [1].
Among children who reach outpatient clinics across the
continent, a presumptive diagnosis of malaria is given
in 30%–40% of these cases [2]. Malaria appears there-
fore to be the number one cause of fever, as well as the
leading cause of mortality, in children in Sub-Saharan
Africa [3]. In 2006, the World Health Organization
(WHO) published the following treatment recommen-
dation: “In areas of high stable malaria transmission,
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the prior probability of fever in a child being caused
by malaria is high. Children !5 years of age should
therefore be treated on the basis of a clinical diagnosis
of malaria. There is as yet no evidence to show that
the benefits of parasitological diagnosis in this highly
vulnerable group outweigh the risks of not treating
false-negatives” [4]. Obviously, the prime reason for
this recommendation of blanket antimalarial treatment
is to save lives. It takes into account the lack of sen-
sitivity and lack of specificity of the clinical diagnosis
of malaria [5].
Although this recommendation was probably sound
at the time of its formulation, it should now be reviewed
because of the steady decrease in malaria transmission
that is occurring all over Sub-Saharan Africa. This de-
crease is due to large-scale control [6, 7] and the avail-
ability of reliable, inexpensive, and easy-to-use malaria
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diagnostic tools [8]. One consequence of the falling transmis-
sion rates is that the blanket approach to treatment is not as
safe as it was a decade ago, because the malaria-attributable
fraction of fevers is now substantially lower and therefore the
relative likelihood of missing other potentially fatal diseases has
become higher [9]. To support a change to this recommen-
dation, WHO looks for convincing evidence on the safety of
treating children !5 years old who live in areas endemic for
malaria on the basis of a malaria test result.
The few studies that have looked at the outcome of treating
febrile children who live in areas endemic for malaria on the
basis of a malaria laboratory test suggest that this strategy might
be safe [10–12]. To our knowledge, our study is the first pro-
spective study in an area that is highly endemic for malaria
that took place under routine implementation conditions with
the aim of evaluating the safety of withholding antimalarials
in febrile children who have a negative result for a rapid di-
agnostic test for malaria (RDTm). Our primary interest was
the clinical outcome of the children, namely the rate of com-
plications and deaths, irrespective of any other consideration
(eg, parasitemia). The RDTm testing by health care workers in
both of our study settings was found to be reliable in a previous
study [13].
METHODS
Study Areas
This work is part of a larger project on the introduction of
RDTm in Tanzania and the evaluation of its impact on health
outcomes, drug prescriptions, consultation processes, patient
and health care worker satisfaction, and cost saving (IMALDIA:
Understanding and Improving Malaria Diagnosis in Tanzania).
The present study was performed first in an area of moderate
endemicity and then in an area of high endemicity. This step-
wise design was chosen to ensure the safety of the patients. If
the strategy of withholding antimalarials in febrile children with
a negative malaria test result were shown to be not safe in an
area of moderate endemicity, the second part of the study in
an area of high endemicity would be canceled.
Dar es Salaam. Buguruni Health Center of Ilala Munici-
pality in the city center of Dar es Salaam, Tanzania, was chosen
as a place of recruitment because of its characteristics typical
of the urban setting. This area is moderately endemic for ma-
laria, with parasite rates in the community at ∼1%–4% [14]
and with only 5%–10% of febrile patients being parasitemic
[15].
Signal. Signal is a remote village in the Kilombero Valley
(south-central Tanzania). The local health facility was chosen
because of the ready availability of RDTm, the high percentage
of febrile patients having parasites (∼50%), and the sufficiently
high average number of patients attending daily (30), compared
with the characteristics of the other remote dispensaries in the
Kilombero Valley. RDTm had been introduced in 7 health fa-
cilities in the area 1 year previously, with a 1-day initial training
of all health care workers, a 2-month follow-up of general
performance, and a routine quality assurance of the RDTm
(including lot testing at a WHO reference laboratory) every 3
months. No further training was conducted in the Signal health
facility in the frame of the present study.
Study Subjects
Inclusion criteria were as follows:
• 1. Children were aged from 6 months to 10 years in Dar es
Salaam and from 2 months to !5 years in Signal.
• 2. Children were attending the health facility for the first
time for the present problem.
• 3. There was a history of fever in the previous 48 hours or
axillary temperature of 37.5C at the time of consultation.
• 4. There was an absence of severe illness that required specific
treatment or referral.
• 5. The main complaint was neither injury nor trauma.
Study Procedures
Oral informed consent was obtained from the parent or guard-
ian. Patients were managed at the discretion of the clinicians,
except that the latter were asked to perform an RDTm (ParaHit-
f cassette; Span Diagnostics) and to not prescribe antimalarials
if the result was negative. A blood slide was also prepared as
back-up for retrospective investigation of complicated cases.
Patients were asked to come back to the same health facility
in case of any problem. In Dar es Salaam, parents and guardians
were informed that they would be visited at home after 7 days
( 1 day) to assess whether the child was cured. In Signal, we
asked them to come back on day 7 for the same reason. If they
had not returned on the due day before 2:00 PM, they were
visited at home on the same or on the following day. At each
home, the clinician would ask the parent or guardian about
the status of the child (cured, not improved, or condition wors-
ened) and whether they had gone to another health facility in
the meantime.
If the child were ill between day 0 and day 7 or not cured on
day 7, a new consultation was performed by the usual clinician
of the health facility, and the patient was tested again with either
an RDTm (if the initial RDTm test result had been negative) or
by microscopy (if the initial RDTm test result had been positive).
Patient management was again left to the discretion of the
clinician, and antimalarials were again withheld if the test was
negative. The child was then visited at home on day 14 to check
his or her status. For admitted children, blood slides for malaria
were read by 2 independent expert microscopists.
Children who had positive RDTm results were treated with
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the recommended first-line antimalarial (artemether-lumefan-
trine [Coartem]) and were followed up in the same way as
children who had negative RDTm results. For obvious reasons,
they did not represent a proper control group, because they
represented a clinically very different group of children. Con-
sequently, no tests of significance were performed to compare
the 2 groups.
We calculated that a sample of 500 malaria-negative children
was required to estimate an adverse event rate of 5% with a
precision of 2%. This risk was estimated on the basis of the
sensitivity of routine RDTm (90%) combined with a 50% risk
of complication (defined as hospital admission or death) due
to delayed diagnosis and therefore absence of timely treatment.
The study protocol and related documents were approved
by the Ethikkommission beider Basel (EKBB) in Switzerland
and by the National Institute for Medical Research Review
Board in Tanzania. The procedures followed were in accordance
with the ethical standards of the responsible committee on
human experimentation and with the Helsinki Declaration.
RESULTS
Status at Inclusion
In Buguruni health centre (Dar es Salaam), 300 children with a
median age of 28 months (range, 3–120 months, with 259 [86%]
being5 years old) were included in May–June 2007. One hun-
dred forty-three children (48%) were female. All had a history
of “homa,” the Swahili word for fever, although this was the
main complaint in only 205 (68%) of the cases. The axillary
temperature was 37.5C in 118 (39%) of the children. At in-
clusion, 41 (14%) of the 300 children had a positive RDTm result.
All 41 children with positive results were treated with an anti-
malarial: 35 (85%) received artemether-lumefantrine and the rest
received oral quinine. Thirteen children with positive results
(32%) also received an antibiotic. Except for one child, all chil-
dren with negative results received an antibiotic (cotrimoxazole,
amoxicillin, and injectable penicillin were mostly used).
In the Signal dispensary (Kilombero), 700 children with a
median age of 24 months (range, 2–59 months) were included
from September 2008 through February 2009. Three hundred
forty-one (49%) were females. They all had a history of homa,
which was the main complaint in 604 (86%) of the cases. The
axillary temperature was37.5C in 404 (58%) of the children.
At inclusion, 356 (51%) of the 700 children had a positive
RDTm result. All children with positive results were treated
with an antimalarial: 342 (96%) received artemisinin-lumefan-
trine and the rest received injectable or oral quinine. Sixty-four
(18%) of the 356 children with positive results also received
an antibiotic. Three hundred twelve (91%) of the 344 children
with negative results received an antibiotic.
Spontaneous Attendance before Day 7
In total, 59 (5.9%) of the 1000 children consulted spontane-
ously before day 7, the majority of them (45 [76%]) visiting
the same facility that they visited for the initial consultation.
Among the 603 children who had a negative RDTm result at
inclusion, 49 (8%) (representing 31 [12%] of 259 in Dar es
Salaam and 18 [5%] of 344 in Signal) attended before day 7
(median, 3 days after inclusion), with persisting fever in 37
children (despite antibiotics prescribed initially for 35 of them).
Among the 397 children who had a positive RDTm result at
inclusion, 10 (3%) attended spontaneously before day 7 (me-
dian, 4 days after inclusion), with persisting fever in 5 children
(4 of them had received an antibiotic at inclusion in addition
to the antimalarial) (Figure 1).
Outcome on Day 7 and Day 14
Thirteen (1.3%) of the 1000 children included were lost to follow-
up, either because they had moved or the address was not suf-
ficiently precise. Among the 591 children who had a negative
RDTm result, 573 (97%) were cured on day 7. For the remaining
18 children, 15 were examined before or on day 7 because of
fever, 2 because of diarrhea, and 1 because of a headache. Of
these 18 children, 14 were cured on day 14, 2 died (see below),
and 2 were lost to follow-up after day 7 (both had negative RDTm
results on day 7). Among the 396 children who had a positive
RDTm result, 387 (98%) were cured on day 7 (38 [95%] of 40
in Dar es Salaam and 349 [98%] of 356 in Signal). Eight children
were still febrile (all had a negative blood slide results), and 1
had asthma. All these children were cured on day 14 (1 was lost
to follow-up after day 7) (Figure 1).
Complications
Of the 603 children who had a negative RDTm result at in-
clusion, 4 (1 in Dar es Salaam and 3 in Signal) were hospitalized:
1 on day 2 because of severe sepsis with exanthema, 1 on day
4 because of severe pneumonia, 1 on day 7 because of gastro-
enteritis with severe dehydration, and 1 on day 7 because of
severe anemia without fever. These 4 children had an RDTm
and an expert microscopy for malaria performed upon ad-
mission at the hospital and all gave negative results. Two chil-
dren died (1 with severe sepsis died on day 6, and 1 with severe
pneumonia died on day 8). Among the 397 children who had
a positive RDTm result at inclusion, 1 was hospitalized on day
7, because pneumonia had not responded to the first-line in-
travenous antibiotic treatment (Figure 1).
Subsequent RDTm Results of the Children with Negative Initial
Results Who Consulted before Day 7 or Who Were Not Cured
on Day 7
Among the 603 children who had negative RDTm results at
inclusion, 55 consulted spontaneously before day 7 or were not
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Figure 1. Flow chart of patients in a study of withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test
in Tanzania. BS, [result of] blood slide for malaria; RDTm, [result of] rapid diagnostic test for malaria.
cured on day 7 when we visited them at home. Of these 55
children, 51 had negative RDTm results; one had positive results
on day 4 and two on day 7 (all living in Signal, the area of
high endemicity), and one could not be tested but recovered
on day 14 after receiving erythromycin prescribed in another
health facility. Among the 3 with newly positive results, 1 child
was likely to have had coincidental low-density parasitemia.
Indeed, he had positive results on day 4 and did not respond
to the antimalarial treatment given on that day, but he re-
sponded to an antibiotic given on day 7. Another child had
dysuria at inclusion, received amoxicillin, and recovered, but
he became feverish again at day 5 with dysuria; he had positive
test results at day 7 and was treated with intramuscular quinine
and cotrimoxazole and was cured on day 14. He had either a
coincidental or a new infection. The last child had vomiting
on day 0 and was treated with cotrimoxazole; then, because of
persisting fever, he attended another dispensary on day 2 where
he was not tested for malaria but received oral quinine. He was
cured on day 7 but had positive results by RDTm. He might
have experienced a malaria episode that was not diagnosed on
day 0 because of clinical symptoms that appeared before patent
parasitemia.
DISCUSSION
To our knowledge, our study is the first to provide strong
evidence that withholding antimalarial treatment in children
with fever who have a negative RDTm result in a setting highly
endemic for malaria is safe and does not expose the child to
an increased risk of complication or death. Because the present
study was conducted with programmatic conditions that were
reasonably close to routine, we believe that the results are ap-
plicable more generally.
Complications or Deaths
In this cohort of 1000 feverish children, 60% had a negative
RDTm result at inclusion and were not treated with an anti-
malarial. We did not observe any complication or death due
to malaria among these children. In total, 4 children (0.7%)
were admitted to the hospital and 2 (0.4%) died; malaria test
results on admission were negative for all 4. Our study provides
strong evidence that the strategy is safe, irrespective of the level
of endemicity of malaria. To our knowledge, the only other
study with a follow-up of fever episodes in untreated children
with negative test results (tested by expert microscopy rather
than by RDTm) was the study by Njama-Meya et al [10] in
Kampala, Uganda. That study, designed primarily to assess the
efficacy of antimalarial drugs, was performed in a highly con-
trolled setting and included children with danger signs. No
complication or death due to the withholding of antimalarial
treatment in children with negative test results occurred.
Although the absence of a proper control group did not allow
us to know the usual rate of complications in the absence of
510 • CID 2010:51 (1 September) • d’Acremont et al
any reliable malaria test, the lack of admissions and/or deaths
due to malaria following RDTm use certainly suggested that
this approach is safe. One (0.3%) of the 397 children in the
malaria group and 4 (0.7%) of the 603 children in the non-
malaria group were admitted after first consultation. There was
no death in the malaria group and 2 deaths in the nonmalaria
group. We know that these complications in nonmalaria pa-
tients were not due to undetected malaria parasites, because
we performed 3 malaria tests on each of these children and
none had positive results.
On the basis of 2 previous studies on severe malaria con-
ducted in Tanzania, we knew that the rate of adverse outcomes
is higher in nonmalaria patients, compared with the rate in
malaria patients, because diseases such as pneumonia, typhoid,
and meningitis have a fatality rate at least as high as that of
malaria and because severely ill febrile patients are often mis-
diagnosed as having malaria and therefore do not receive ap-
propriate antibiotics [16, 17]. Such a trend was also found in
our study, which included less severe cases. Therefore, accurate
diagnosis is essential even at the outpatient level to prevent the
further occurrence of complications and deaths. This is espe-
cially true now, because of the regular decrease in malaria trans-
mission in many settings of endemicity [6, 18, 19] and therefore
the relative increase of fevers due to other treatable causes in
many places in Africa.
Outcome on Day 7
In our study, the percentage of children not cured on day 7
was very low in both groups (2% in the malaria group versus
3% in the nonmalaria group). The 9 malaria patients who were
still sick after 1 week all had a negative result for a follow-up
blood slide test. Therefore, it is very likely that they were suf-
fering from another fever cause, with parasitemia being coin-
cidental. For the nonmalaria cases, 17 of the 18 children who
were not cured on day 7 had received an antibiotic, which
suggests that they had either a viral disease with prolonged
fever or a bacterial disease resistant to the first-line antibiotic.
In these 2 areas, we know that nonmalaria fevers are composed
of 56% acute respiratory infections, 10% gastroenteritis, 6%
urinary infections, 3% typhoid, 3% other documented infec-
tions, and 22% fever of unknown origin. Furthermore, 68% of
acute respiratory infections and 31% of gastroenteritis episodes
are associated with documented viruses (d’Acremont et al, un-
published data, 2010) that obviously do not respond to anti-
biotics and that therefore tend to persist longer than malaria
episodes treated with an effective drug. For nonmalaria fevers
due to bacteria, the high rate of resistance to first-line antibiotics
in Tanzania also leads to prolonged episodes [20].
Outcome of Children with Negative Initial Results and Positive
Subsequent Results
There are several reasons for which a malaria test can yield
negative initial results and positive subsequent results within a
few days: (1) coincidental low-density malaria fluctuating
around the threshold of detection of a malaria test; (2) symp-
toms and signs appearing before parasites can be detected in
the blood by conventional tests, especially in nonimmune in-
fants or young children; (3) new infections; and (4) failure of
the test (negative test result in the presence of normal density
parasitemia). Coincidental or new infection is the most likely
explanation for 2 of the 3 patients with negative initial results
and positive subsequent results. In an area of high endemicity,
it is expected to have some children presenting with new par-
asitemia every day. We found in our sample of children from
Signal an incidence of malaria in the 7 days after a negative
test result of 0.45 episodes per child per year, which is lower
than expected. This rate is close to the one reported by Njama-
Meya et al [10] (0.42 episodes per child per year) and found
by using microscopy instead of RDTm. It is also similar to the
incidence of malaria episodes in infants (0.43 episodes per in-
fant per year) found by using passive-case detection in the main
town of Kilombero District in the year 2000 [21]. Failure of
the RDTm to detect parasitemia of a density high enough to
be detected by conventional test probably did not occur in our
study, because all 3 patients who had negative RDTm results
at inclusion also had negative results by expert microscopy. In
the study by Njama-Meya et al [10], there were 4 children with
negative results by initial expert microscopy but positive re-
sults by subsequent expert microscopy. False-negative results
do exist with RDTm but possibly at a lower rate than with ex-
pert microscopy, as demonstrated by Ochola et al [22] and
Bell et al [23].
CONCLUSIONS
In 2 Tanzanian settings (1 urban and 1 rural), the strategy of
RDTm-based diagnosis and treatment proved to be safe, with
no case that was missed by a negative initial RDTm result
ending in complication or death. The sample size of our study
allowed us to say with 95% confidence that the probability of
such an unfavorable event was between 0% and 0.5% (rule of
3) [24]. Although our study does not provide the definite an-
swer in this matter, it contributes important evidence toward
a change in policy in malaria diagnosis and treatment and thus
toward a better management of fever in countries endemic for
malaria.
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